With more than 10 million procedures performed annually in Europe, nuclear medicine plays a vital role in modern healthcare, from early cancer detection to targeted therapies that are transforming patient care. Yet despite its profound impact, nuclear medicine remains insufficiently understood by the public, policymakers, and even within the broader healthcare community.
Raising awareness about the benefits of nuclear medicine is essential to improving patient access, securing sustainable funding, attracting the next generation of professionals, and ensuring that innovation reaches those who need it most.
That is why we launched the European Nuclear Medicine Day, an annual event dedicated to bringing the benefits, challenges, and potential of nuclear medicine into focus. Through this initiative, we aim to strengthen collaboration with policymakers, healthcare systems, patient organisations, and the public, and to ensure that nuclear medicine receives the recognition and support it deserves in shaping the future of healthcare in Europe and beyond.
Towards Equitable Patient Access to Nuclear Medicine in Europe
A Joint Call to Action
As an outcome of the first European Nuclear Medicine Day, the European Association of Nuclear Medicine and Nuclear Medicine Europe jointly developed a set of concrete recommendations built on the insights, expertise and perspectives shared throughout the day’s discussions. Structured around three conditions for equitable patient access – regulation, supply and infrastructure, and workforce – these recommendations form a joint advocacy agenda directed at EU institutions, Member States, regulatory bodies and the broader healthcare community.
Organisation
The organising committee is composed of the European Association of Nuclear Medicine (EANM), the industry association Nuclear Medicine Europe and their dedicated Communications Working Groups.
